MRNA
Moderna, Inc.
A biotechnology company that uses messenger RNA (mRNA) to build medicines and vaccines, best known for Spikevax, its COVID-19 vaccine. Founded in 2010 in Cambridge, Massachusetts, it grew out of the venture-building firm Flagship Pioneering with help from scientists including MIT's Robert Langer. Its name blends "modified" and "RNA"—and conveniently hides the word "modern."
CUSIP: 60770K107HealthcareUS1 holder
Total Value
$807.2K
Total Shares
11.5K
Net Share Change
-63.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
